Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity Ceryvyn Therapeutics Limited ABN/ARBN Financial year ended: 32 006 340 567 30 June...
Appendix 4G and Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Ceryvyn Therapeutics Limited on 6ix
Earlier from Ceryvyn Therapeutics
Later from Ceryvyn Therapeutics
- Proposed issue of securities - CYV
- Annual General Meeting Date
- Change in substantial holding
- Notice of Annual General Meeting/Proxy Form
Follow Ceryvyn Therapeutics into a list and get an email when it puts out news.
Follow Ceryvyn Therapeutics